
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
Chicago-Penile implants provide greater patient satisfaction than eithermedical therapy or intracavernosal injections for erectile dysfunction,said Detroit researchers during a presentation yesterday.





